Compounds > 13-oxo-9,11-octadecadienoic acid
Page last updated: 2024-09-04

13-oxo-9,11-octadecadienoic acid and 2,4,2',4'-Tetrahydroxychalcone

13-oxo-9,11-octadecadienoic acid has been researched along with 2,4,2',4'-Tetrahydroxychalcone in 1 studies

Compound Research Comparison

Studies
(13-oxo-9,11-octadecadienoic acid)		Trials
(13-oxo-9,11-octadecadienoic acid)		Recent Studies (post-2010)
(13-oxo-9,11-octadecadienoic acid)		Studies
(2,4,2',4'-Tetrahydroxychalcone)		Trials
(2,4,2',4'-Tetrahydroxychalcone)		Recent Studies (post-2010) (2,4,2',4'-Tetrahydroxychalcone)
505906

Protein Interaction Comparison

ProteinTaxonomy13-oxo-9,11-octadecadienoic acid (IC50)2,4,2',4'-Tetrahydroxychalcone (IC50)
Polyphenol oxidase 2Agaricus bisporus5
TyrosinaseMus musculus (house mouse)5
TyrosinaseHomo sapiens (human)0.07
Beta-secretase 1Homo sapiens (human)0.62

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kishore, N; Kumar, P; Shanker, K; Verma, AK1

Reviews

1 review(s) available for 13-oxo-9,11-octadecadienoic acid and 2,4,2',4'-Tetrahydroxychalcone

ArticleYear
Human disorders associated with inflammation and the evolving role of natural products to overcome.
    European journal of medicinal chemistry, 2019, Oct-01, Volume: 179

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biological Products; Cardiovascular Diseases; Humans; Inflammation; Neoplasms; Skin Diseases

2019